US 12414983
CD200AR ligands for cancer immunotherapy
granted A61KA61K2039/5152A61K2039/545
Quick answer
US patent 12414983 (CD200AR ligands for cancer immunotherapy) held by Regents of the University of Minnesota expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/5152, A61K2039/545, A61K2039/552, A61K2039/572